Abstract

This study uses a difference-in-differences approach with the Securities and Exchange Commission’s Regulation SHO as the focus and examine whether the threat of short-selling can twist banks’ decisions. Our results show that leverage, operating risk, systemic risk, tail risk, and stock volatility are lower for treatment than for control banks listed in the Russell 3000 index. The evidence shows that treatment banks face looser short-selling constraints under the regulation, which reduces risk-taking. Additionally, these effects are driven mainly by treatment banks hampered by poor corporate governance. Overall, our paper provides novel evidence that short-selling threats can stabilize the financial market.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.